23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammationmirador22024-11-20T04:30:05-08:0011.20.24|
Endpoints News Names Mirador Therapeutics a 2024 “Endpoints 11” Winnermirador22024-09-27T05:30:15-07:009.27.24|
Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officermirador22024-09-17T07:33:32-07:009.17.24|
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseasesmirador22024-03-21T11:14:13-07:003.21.24|
